Skip to content

LS301-IT 0.1 mg/kg

DRUG2 trials

Sponsors

Integro Theranostics

Conditions

Breast CancerDCISInvasive Duct Carcinoma of BreastNon Small Cell Lung Cancer (NSCLC)